Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PE Biosystems (PEB) -- Ignore unavailable to you. Want to Upgrade?

To: Don Dorsey who wrote (12)	1/26/1998 2:44:00 PM
From: Don Dorsey	Read Replies (1) \| Respond to of 122

Here is some info about one of the top guys at PKN. Galileo Adds Dr. Mark C. Rogers To Board of Directors Business Wire - January 26, 1998 12:58 STURBRIDGE, Mass.--(BW HealthWire)--Jan. 26, 1998--Galileo Corporation (NASDAQ National Market:GAEO) announced today that Dr. Mark C. Rogers, M.D., MBA, Senior Vice President, Corporate Development and Chief Technology Officer of the Perkin-Elmer Corporation since 1996, has joined Galileo's Board of Directors. Prior to joining the Perkin-Elmer Corporation, Dr. Rogers was Vice Chancellor for Health Affairs of Duke University Medical Center and Executive Director and Chief Executive Officer of Duke Hospital and Health Network. He was also Senior Fellow, Center for Health Policy Research and Education, as well as, Professor of Business Administration at Fuqua School of Business. From 1977 through 1992, Dr. Rogers held several positions with the Johns Hopkins University School of Medicine, Baltimore, Maryland, including: Director of Pediatric Intensive Care Unit, Professor of Pediatrics, Anesthesiologist-in-Chief, Distinguished Faculty Professor and Chairman, Department of Anesthesiology and Critical Care Medicine, and the Associate Dean for Clinical Affairs. Dr. Rogers is a Fulbright Scholar and has been a visiting scholar or Professor in over 50 countries. He is an internationally respected expert in Pediatrics, Anesthesiology and Critical Care with over 200 medical publications to his credit. William T. Hanley, President and Chief Executive Officer, commented, "Dr. Rogers brings an extraordinary level of experience and expertise to the medical and analytical segments of our business. His counsel and guidance will represent significant contributions to our future successes in these businesses." In other news, the Company will be announcing its first quarter results for fiscal year 1998 on January 28, 1998. The Company will hold a conference call to discuss its results and operations on the same date. Galileo develops, manufactures and markets products based on its core fiberoptics and electro-optics technologies for applications in medical products and instruments, telecommunication products, analytical detector instruments and office equipment. Galileo markets its products to OEMs, through marketing partners and direct to end-users. Leisegang Medical, a wholly-owned subsidiary, develops, manufactures, and markets women's health-related medical products. Please visit our web site at www.galileocorp.com for additional information. CONTACT: Galileo Corporation Gregory Riedel 508/347-4222